Clinical Pharmacology and Drug Toxicity Practice Questions

Q: A 35-year-old male presents to the emergency department with complaints of blurred vision, dizziness, and severe headache after ingesting an unknown quantity of homemade alcohol earlier in the day. On examination, he is disoriented. Laboratory tests reveal severe metabolic acidosis with a high anion gap. Which metabolite is primarily responsible for the toxicity in this case?

Formic acid. ***Formic acid***- The severe clinical toxicity, including **high anion gap metabolic acidosis**, visual impairment (e.g., blurred vision, blindness), and central nervous system depression, is primarily due to the accumulation of **formic acid** (formate), which is the final toxic metabolite of methanol [1].**Formic acid** inhibits **cytochrome c oxidase** in the retina and brain, leading to cytotoxic hypoxia, specifically affecting the optic nerve and basal ganglia.*Methanol*- **Methanol** itself causes mild inebriation and CNS depression, but it is relatively non-toxic; the severe symptoms arise only after its metabolism begins [2].The signs and symptoms (blurred vision, severe acidosis) that lead to presentation typically occur after a latent period (12-24 hours) as the relatively slow conversion of methanol to **formate** occurs [2].*Formaldehyde*- **Formaldehyde** is the intermediate metabolite formed from methanol via **alcohol dehydrogenase (ADH)**; however, it is rapidly converted to formic acid by **aldehyde dehydrogenase (ALDH)** [1].Due to its rapid metabolism, **formaldehyde** does not accumulate significantly and is therefore not the major culprit responsible for the sustained **high anion gap acidosis** and end-organ damage seen clinically.*Acetic acid*- **Acetic acid** is the final, non-toxic metabolite of **ethanol** metabolism (ethanol -> acetaldehyde -> acetic acid).Ingestion of methanol does not result in the production of **acetic acid**, and this substance plays no role in the clinical picture of methanol poisoning.

Q: A 25-year-old woman presents to the emergency department 6 hours after ingesting a large quantity of paracetamol tablets. What is the most likely progression of paracetamol poisoning in this case?

Increase in liver enzymes starting around 24 hours. ***Increase in liver enzymes starting around 24 hours*** - Phase 2 of paracetamol toxicity, occurring **24–72 hours post-ingestion**, is characterized by the onset of **hepatotoxicity**, marked by rising **AST** and **ALT** levels. - The patient is currently 6 hours post-ingestion (late Phase 1), so the most likely progression is entering Phase 2, where biochemical evidence of liver damage begins around 24 hours and continues to rise. *Liver failure within 24 hours* - **Acute liver failure** (manifested by coagulopathy, jaundice, and encephalopathy) typically develops around 3 to 4 days (72–96 hours) post-ingestion (Phase 3). - Within the first 24 hours, symptoms are usually mild or absent (Phase 1: nausea, vomiting, or asymptomatic). *Paracetamol achieves peak concentration within 4 hours* - While **peak plasma concentration** for standard paracetamol typically occurs around 4 hours post-ingestion, this pharmacokinetic event has already occurred since the patient presents at 6 hours. - The question asks for the subsequent toxicological *progression* (clinical course), not a past pharmacokinetic event. *Recovery within 72 hours* - Recovery (Phase 4) typically occurs after the peak injury period (around 4 days or later), especially with effective antidote treatment (**N-acetylcysteine**). - Given the ingestion of a **large quantity**, the patient is expected to progress through Phase 2 (**hepatotoxicity** at 24-72 hours) and possibly Phase 3 (peak toxicity at 72-96 hours), not recover within 72 hours.

Q: A male patient complained of imbalance, numbness of the foot, and muscle weakness. On history taking, he revealed that he has been taking multivitamin tablets more than the prescribed dose for 1 year. Which of the following is the most likely cause of the associated symptoms seen in this patient?

Vitamin B6 toxicity. ***Vitamin B6 toxicity*** - Chronic ingestion of high-dose **pyridoxine** (Vitamin B6) is a well-known cause of **sensory polyneuropathy**, which manifests as numbness (paresthesia) and gait imbalance (**ataxia**). - The toxicity primarily targets the sensory neurons of the **dorsal root ganglia**, leading to the observed sensory and motor deficits (muscle weakness). *Vitamin D toxicity* - This condition primarily causes **hypercalcemia**, leading to symptoms such as nausea, vomiting, confusion, and generalized weakness, often affecting renal function. - It is not typically associated with a chronic, distal, sensory-dominant **peripheral neuropathy** causing numbness and foot imbalance. *Vitamin C toxicity* - Vitamin C (ascorbic acid) is generally safe; high doses typically result in mild symptoms like gastrointestinal distress and an increased risk of developing **calcium oxalate kidney stones**. - It does **not** cause neurotoxic effects such as peripheral neuropathy or chronic ataxia. *Vitamin A toxicity* - Chronic hypervitaminosis A involves symptoms such as **hepatotoxicity**, dry skin/cheilitis, **bone and joint pain**, and pseudo-tumor cerebri (increased intracranial pressure). - While neurological symptoms like headache may occur due to increased pressure, clear-cut **sensory polyneuropathy and ataxia** are not characteristic features.

Q: A 50-year-old factory worker was brought to the emergency room with complaints of headache, vomiting, and blurring of vision after he consumed local spirit. Which of the following is used for the treatment of his condition?

Fomepizole. ***Fomepizole***- Fomepizole is the preferred antidote for **methanol** and **ethylene glycol** poisoning because it competitively inhibits the enzyme **alcohol dehydrogenase** (ADH).- By inhibiting ADH, it prevents the metabolism of methanol into its toxic metabolite, **formic acid**, which is responsible for the characteristic **ocular toxicity** (blurring of vision) and **metabolic acidosis** seen in this patient.*Flumazenil*- Flumazenil is a competitive antagonist used to reverse the effects of **benzodiazepines**, primarily in cases of overdose or to reverse procedural sedation.- It has no role in the treatment of **methanol poisoning**, which causes toxicity via the accumulation of **formic acid**.*N-acetyl cysteine*- **N-acetyl cysteine (NAC)** is the specific antidote for **acetaminophen** (paracetamol) overdose, as it replenishes **glutathione** stores in the liver.- It is ineffective in the treatment of **methanol poisoning**, which requires ADH inhibition or **hemodialysis** to remove the toxins.*Naloxone*- **Naloxone** is an opioid antagonist used specifically to rapidly reverse the effects of **opioid overdose** by competing for the opioid receptors.- The patient's symptoms (headache, vomiting, blurring of vision) are classic for **methanol toxicity** and are not indicative of opioid overdose.

Q: The application of the following product can lead to development of: (Recent NEET Pattern 2016-17)

Methemoglobinemia. ***Methemoglobinemia (Correct)*** - EMLA cream contains **lidocaine** and **prilocaine**, both of which are **amide-type local anesthetics** - Prilocaine, in particular, can cause methemoglobinemia due to its metabolite, **o-toluidine**, which oxidizes hemoglobin to methemoglobin - While methemoglobinemia is rare with proper use, it is a known and serious adverse effect, especially when applied to large areas, on broken skin, or in infants - This is the most specific adverse effect associated with prilocaine in EMLA cream *Seizures (Incorrect)* - Seizures are a known systemic toxicity of local anesthetics like lidocaine and prilocaine but are usually associated with **very high systemic concentrations**, often from accidental intravenous injection or excessive application over large areas - While possible with overdose, methemoglobinemia is a more specific and direct concern linked to prilocaine's metabolic pathway - CNS toxicity typically requires systemic absorption beyond what occurs with proper topical use *Depression (Incorrect)* - Depression is **not a direct or common adverse effect** of EMLA cream or its components - Systemic absorption of local anesthetics can cause central nervous system effects, but depression is generally not among them - CNS effects more commonly involve excitation (restlessness, tremors) or sedation depending on the dose *Hypertension (Incorrect)* - Local anesthetics generally cause **vasodilation** at therapeutic doses, potentially leading to **hypotension** rather than hypertension, especially with systemic absorption - Hypertension is not a characteristic side effect associated with the topical application of EMLA cream - The cardiovascular effects of local anesthetics, when present, typically involve decreased blood pressure and myocardial depression

Q: Which of the following is a non-narcotic active principle of the opium poppy shown in the image below?

Noscapine. ***Noscapine*** - Noscapine is an **isoquinoline alkaloid** derived from the **opium poppy** (Papaver somniferum), which is depicted in the image. - It is a **non-narcotic antitussive** (cough suppressant) agent, meaning it does not have significant analgesic properties or potential for abuse typical of narcotics. *Morphine* - Morphine is a potent **narcotic analgesic** and the **most abundant opioid alkaloid** found in opium. - It works by binding to **opioid receptors** in the central nervous system, leading to pain relief, euphoria, and respiratory depression. *Codeine* - Codeine is another **narcotic opioid** derived from the opium poppy, known for its analgesic and antitussive effects. - It is a **prodrug** that is metabolized to morphine in the liver by the CYP2D6 enzyme, contributing to its opioid effects. *Thebaine* - Thebaine is an **opioid alkaloid** found in opium, but unlike morphine and codeine, it has little therapeutic use as an analgesic. - It is primarily used as a precursor in the industrial synthesis of other opioids, such as **oxycodone** and **naloxone**.

Q: The toxin shown below will cause:

Gangrene of fingers and toes. ***Gangrene of fingers and toes*** - The image displays **ergot sclerotia** (dark, elongated structures) growing on a grain stalk, which produce **ergot alkaloids**. - **Ergotism**, caused by ingestion of these alkaloids, leads to intense **vasoconstriction**, resulting in **ischemia** and eventually **gangrene** of the extremities, classically fingers and toes. *Opisthotonus* - **Opisthotonus** is a severe hyperextension and spasticity of the head, neck, and spinal column. - It is typically associated with conditions like **tetanus** or severe brain injury, not ergot poisoning. *DIC* - **Disseminated Intravascular Coagulation (DIC)** is a disorder characterized by systemic activation of blood coagulation, leading to microthrombi formation and consumption of clotting factors and platelets. - While various toxins can induce DIC, **ergot alkaloids** primarily cause vasoconstriction and ischemic tissue damage, rather than widespread coagulation imbalance directly. *Lock jaw* - **Lockjaw** or **trismus** is a sustained spasm of the masticatory muscles, preventing the mouth from opening. - This is a classic symptom of **tetanus**, caused by the neurotoxin **tetanospasmin**, not ergot alkaloids.

Q: The condition shown in the image can be seen with all of the following EXCEPT:

Flupirtine. The image displays severe **gingival hypertrophy**, characterized by an overgrowth of gum tissue that covers a significant portion of the teeth. ***Flupirtine*** - **Flupirtine** is a centrally acting non-opioid analgesic that is not associated with gingival hypertrophy. - Its adverse effects are primarily related to neurological and hepatic systems, such as **dizziness**, **nausea**, and **liver enzyme elevation**. *M4 AML* - **Acute Myeloid Leukemia (AML) M4 subtype**, also known as acute myelomonocytic leukemia, is frequently associated with **gingival infiltration** and hypertrophy due to the proliferation of leukemic cells. - This infiltrative process can cause significant gingival enlargement, sometimes leading to tooth displacement and difficulty with oral hygiene. *Cyclosporine* - **Cyclosporine** is an immunosuppressant commonly used in organ transplantation and autoimmune diseases, and it is a well-known cause of drug-induced gingival hypertrophy. - The mechanism involves increased collagen synthesis and reduced collagen degradation in the gingival connective tissue. *Nifedipine* - **Nifedipine** is a calcium channel blocker used to treat hypertension and angina, and it is another common medication that causes drug-induced gingival hypertrophy. - The exact mechanism is not fully understood but is thought to involve altered fibroblast activity and collagen accumulation in the gingiva.

Q: A 6-year-old child was having multiple vomiting episodes after eating at mid-day meal scheme in school. The Doctor at PHC gave injectable anti-emetics after which the child developed following posturing. What is the clinical diagnosis and what drug should be given to counteract this posturing?

Oculogyric spasm, promethazine. ***Oculogyric spasm, promethazine*** - The image shows upward deviation of the eyes, known as an **oculogyric spasm**, a form of **acute dystonia**. This is a common extrapyramidal symptom (EPS) caused by dopamine receptor blocking antiemetics (e.g., metoclopramide, prochlorperazine) or antipsychotics. - **Promethazine**, an antihistamine with anticholinergic properties, or other anticholinergics like **benztropine** or **diphenhydramine**, are effective in treating acute dystonias by restoring the dopamine-acetylcholine balance in the basal ganglia. *Tardive dyskinesia, benztropine* - **Tardive dyskinesia** presents with involuntary, repetitive, and often bizarre movements (e.g., lip smacking, tongue protrusion), typically developing after chronic exposure to dopamine-blocking agents, not acutely. - While benztropine can treat some EPS, it is **not the primary treatment for tardive dyskinesia**, which often requires different management strategies, including switching medications or using VMAT2 inhibitors. *Malignant neuroleptic syndrome, dantrolene* - **Neuroleptic malignant syndrome (NMS)** is a severe, life-threatening reaction characterized by rigidity, fever, altered mental status, and autonomic instability. This differs from the isolated oculogyric spasm observed. - **Dantrolene** is used to treat the muscle rigidity and hyperthermia in NMS, along with bromocriptine for dopamine activity, but is not indicated for acute dystonia. *Akathisia, propranolol* - **Akathisia** is an unpleasant subjective sensation of inner restlessness and the need to move, often manifesting as pacing or fidgeting. This is distinct from the sustained muscle contractions seen in dystonia. - While propranolol can be used to treat akathisia, it would not resolve an **oculogyric spasm**.

Question 1

A 35-year-old male presents to the emergency department with complaints of blurred vision, dizziness, and severe headache after ingesting an unknown quantity of homemade alcohol earlier in the day. On examination, he is disoriented. Laboratory tests reveal severe metabolic acidosis with a high anion gap. Which metabolite is primarily responsible for the toxicity in this case?

Accepted Answer

Formic acid

Answer

Formaldehyde

Answer

Acetic acid

Answer

Methanol

Question 2

A 25-year-old woman presents to the emergency department 6 hours after ingesting a large quantity of paracetamol tablets. What is the most likely progression of paracetamol poisoning in this case?

Accepted Answer

Increase in liver enzymes starting around 24 hours

Answer

Recovery within 72 hours

Answer

Paracetamol achieves peak concentration within 4 hours

Answer

Liver failure within 24 hours

Question 3

A male patient complained of imbalance, numbness of the foot, and muscle weakness. On history taking, he revealed that he has been taking multivitamin tablets more than the prescribed dose for 1 year. Which of the following is the most likely cause of the associated symptoms seen in this patient?

Accepted Answer

Vitamin B6 toxicity

Answer

Vitamin D toxicity

Answer

Vitamin C toxicity

Answer

Vitamin A toxicity

Question 4

A 50-year-old factory worker was brought to the emergency room with complaints of headache, vomiting, and blurring of vision after he consumed local spirit. Which of the following is used for the treatment of his condition?

Accepted Answer

Fomepizole

Answer

Flumazenil

Answer

N-acetyl cysteine

Answer

Naloxone

Question 5

A 55-year-old diabetic patient on metformin develops lactic acidosis after a contrast-enhanced CT scan. What is the mechanism by which metformin contributed to this complication?

Accepted Answer

Inhibition of mitochondrial complex I leading to increased anaerobic metabolism

Answer

Direct nephrotoxicity causing acute kidney injury

Answer

Stimulation of insulin secretion causing hypoglycemia

Answer

Increased hepatic gluconeogenesis

Question 6

The application of the following product can lead to development of: (Recent NEET Pattern 2016-17)

Accepted Answer

Methemoglobinemia

Answer

Seizures

Answer

Depression

Answer

Hypertension

Question 7

Which of the following is a non-narcotic active principle of the opium poppy shown in the image below?

Accepted Answer

Noscapine

Answer

Morphine

Answer

Codeine

Answer

Thebaine

Question 8

The toxin shown below will cause:

Accepted Answer

Gangrene of fingers and toes

Answer

Opisthotonus

Answer

DIC

Answer

Lock jaw

Question 9

The condition shown in the image can be seen with all of the following EXCEPT:

Accepted Answer

Flupirtine

Answer

M4 AML

Answer

Cyclosporine

Answer

Nifedipine

Question 10

A 6-year-old child was having multiple vomiting episodes after eating at mid-day meal scheme in school. The Doctor at PHC gave injectable anti-emetics after which the child developed following posturing. What is the clinical diagnosis and what drug should be given to counteract this posturing?

Accepted Answer

Oculogyric spasm, promethazine

Answer

Tardive dyskinesia, benztropine

Answer

Malignant neuroleptic syndrome, dantrolene

Answer

Akathisia, propranolol

Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity — MCQs

On this page

Practice by Chapter

Want unlimited practice?